Leerink Partnrs Analysts Lower Earnings Estimates for AGIO
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Investment analysts at Leerink Partnrs decreased their Q2 2025 earnings estimates for shares of Agios Pharmaceuticals in a research note issued to investors on Monday, April 28th. Leerink Partnrs analyst A. Berens now anticipates that the biopharmaceutical company will post earnings per share of ($1.81) for the […]
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Investment analysts at Leerink Partnrs decreased their Q2 2025 earnings estimates for shares of Agios Pharmaceuticals in a research note issued to investors on Monday, April 28th. Leerink Partnrs analyst A. Berens now anticipates that the biopharmaceutical company will post earnings per share of ($1.81) for the […]
